financetom
Business
financetom
/
Business
/
CNA Financial's Q1 Core Earnings, Revenue Rise; Maintains Quarterly Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CNA Financial's Q1 Core Earnings, Revenue Rise; Maintains Quarterly Dividend
May 6, 2024 4:54 AM

07:37 AM EDT, 05/06/2024 (MT Newswires) -- CNA Financial ( CNA ) reported Q1 core income Monday of $1.30 per diluted share, up from $1.19 a year earlier.

Three analysts polled by Capital IQ expected $1.39.

Total revenue for the commercial insurer for the quarter ended March 31 was $3.02 billion, up from $2.78 billion a year earlier.

One analyst surveyed by Capital IQ expected $3.49 billion.

The company said it maintained its quarterly dividend at $0.44 per share, payable June 6 to shareholders of record as of May 20.

Price: 44.30, Change: -0.10, Percent Change: -0.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tilray Brands' Tilray Medical Division Launches Redecan Cannabis Brand in Australia
Tilray Brands' Tilray Medical Division Launches Redecan Cannabis Brand in Australia
Sep 21, 2024
08:14 AM EDT, 09/18/2024 (MT Newswires) -- Tilray Brands' ( TLRY ) Tilray Medical division said Wednesday that its Redecan certified medical cannabis products are now available in Australia. Tilray Medical said the products it is selling in Australia include 15g Redecan PC THC28 Purple Churro and 15g Redecan SA THC28 Space Age Cake. ...
Dynacor Group Reports August Gold Sales of US$26.3 Million
Dynacor Group Reports August Gold Sales of US$26.3 Million
Sep 21, 2024
08:12 AM EDT, 09/18/2024 (MT Newswires) -- Dynacor Group ( DNGDF ) , a gold ore industrial company servicing artisanal and small-scale miners, on Wednesday announced unaudited gold sales of US$26.3 million in August, a 22% increase over last year. The increase was due to higher sales prices that were partially offset by a decrease in volume. The year-to-date sales...
Vivos Therapeutics' Sleep Disorder Treatment Device Receives FDA Clearance
Vivos Therapeutics' Sleep Disorder Treatment Device Receives FDA Clearance
Sep 21, 2024
07:37 AM EDT, 09/18/2024 (MT Newswires) -- Vivos Therapeutics ( VVOS ) said Wednesday that it received the US Food and Drug Administration's 510(k) clearance for its oral medical device, which treats moderate to severe obstructive sleep apnea. The company said the noninvasive, safe, and effective device is part of its CARE line and intended for children diagnosed with obstructive...
Top Premarket Gainers
Top Premarket Gainers
Sep 21, 2024
07:54 AM EDT, 09/18/2024 (MT Newswires) -- Portage Biotech ( PRTG ) shares more than doubled pre-bell Wednesday, adding to Tuesday's 16% increase. Veea (VEEA) shares surged 58%, rebounding from a slump in the previous session. Intuitive Machines ( LUNR ) shares rose 54% after the company said late Tuesday it was awarded a Near Space Network contract valued up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved